Anastasios Dimou in Rochester, Minnesota

Medical School: Sorry, his university is not listed
Graduation Year: 2007
The Primary Medical Specialty for Anastasios Dimou is listed as: Medical Oncology
Approximate Years of Experience: 17
PAC (PECOS ID)#: 5092937649
NPI #: 1265729834
NPI Created On: 07/05/2011
NPI Last Updated Listed as: 08/13/2020
Primary Taxonomy Code: 390200000X
License Number:
LL37214
Listed Gender: Male

Services and Procedures include:

1. Hydration infusion into a vein
2. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
3. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
6. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
7. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
8. Infusion of chemotherapy into a vein using push technique
9. Infusion of different chemotherapy drug or substance into a vein
10. Infusion of chemotherapy into a vein up to 1 hour
11. Infusion of chemotherapy into a vein
12. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
13. New patient office or other outpatient visit, typically 60 minutes
14. Established patient office or other outpatient visit, typically 5 minutes
15. Established patient office or other outpatient visit, typically 15 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Established patient office or other outpatient, visit typically 40 minutes
18. Subsequent hospital inpatient care, typically 35 minutes per day
19. Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
20. Injection, atropine sulfate, 0.01 mg